Confirming Tapinarof’s Efficacy and Safety Across Atopic Dermatitis Severities, with Justin Greiwe, MDByVictoria Johnson,Justin Greiwe, MDMarch 5th 2025Greiwe discussed findings from the phase 3 ADORING 1 and 2 trials in people as young as 2 years of age.